General Catalyst leads Series B round for Elysium Health


Elysium Health Inc, a provider of dietary supplements, has secured $20 million in Series B financing. General Catalyst led the round with participation from other investors that included Breyer Capital, Morningside Ventures and Sound Ventures.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!